De-Risking Early Drug Discovery
Z7 Biotech Ltd. is a specialist early discovery partner focused on target validation, signalling mechanisms, and structure-function relationships. We perform mechanism-defining studies at the hit-to-lead stage, reducing biological uncertainty before clinical development. At Z7 we deliver solutions to complex problems where conventional discovery workflows fall short.
We are the go-to Contract Research Organisation (CRO) for:
-
Orphan GPCRs
-
Biased signalling programmes
-
Transporters and ion channels
-
Grant-backed academic translation
-
First-in-class target validation
We provide innovative solutions to hard, "cold start", early stage drug discovery - accelerating drug discovery with precision pharmacology.
Targets
-
G-Protein Coupled Receptors
-
Membrane Bound Targets
-
Soluble Proteins
Capabilities
-
Target Engagement Assays
-
Signalling Assays
-
Ligand Binding Assays
-
Bespoke Assay Development
OUR VALUES
EXCELLENCE
We invest in our highly skilled staff scientists and adhere to rigorous methodologies to enable reliable results and insightful interpretation.
INNOVATION
We are constantly developing and integrating the best and most cutting edge technologies and workflows into our work to be able to offer our clients world-class research and answers to difficult scientific questions.
COLLABORATION
Our work with both our industry and academic partners drives our knowledge, our skills, and some of our tried and tested technology further than any of us can do alone.